15 December 2016 - One day after federal prosecutors unsealed a criminal information against the former CEO of Heritage Pharmaceuticals, 20 state attorneys general filed an antitrust lawsuit against six generic drug makers.

The complaint filed in federal court in Connecticut makes clear which companies could be implicated in the antitrust investigation federal prosecutors are pursuing. As Forbes reported on Wednesday, those companies are Mylan, Teva Pharmaceuticals, Citron Pharma, Heritage Pharmaceuticals and Aurobindo Pharmaceuticals. In addition, the state attorneys general sued Mayne Pharmaceuticals.

Read Forbes Magazine article